UBS Group AG Buys 86,065 Shares of Axcelis Technologies, Inc. $ACLS

Posted by George Bondi on May 13th, 2026

UBS Group AG increased its stake in shares of Axcelis Technologies, Inc. (NASDAQ:ACLS – Free Report) by 67.6% during the 4th quarter, Holdings Channel reports. The fund owned 213,388 shares of the semiconductor company’s stock after acquiring an additional 86,065 shares during the period. UBS Group AG’s holdings in Axcelis Technologies were worth $17,144,000 as of its most recent SEC filing.

A number of other large investors have also bought and sold shares of ACLS. EverSource Wealth Advisors LLC increased its stake in Axcelis Technologies by 29.7% in the third quarter. EverSource Wealth Advisors LLC now owns 585 shares of the semiconductor company’s stock valued at $57,000 after purchasing an additional 134 shares in the last quarter. CWM LLC boosted its position in shares of Axcelis Technologies by 5.8% during the 4th quarter. CWM LLC now owns 2,623 shares of the semiconductor company’s stock worth $211,000 after purchasing an additional 143 shares in the last quarter. Smartleaf Asset Management LLC grew its stake in shares of Axcelis Technologies by 18.6% in the 3rd quarter. Smartleaf Asset Management LLC now owns 957 shares of the semiconductor company’s stock valued at $93,000 after buying an additional 150 shares during the period. Vanguard Personalized Indexing Management LLC grew its stake in shares of Axcelis Technologies by 2.3% in the 3rd quarter. Vanguard Personalized Indexing Management LLC now owns 9,243 shares of the semiconductor company’s stock valued at $902,000 after buying an additional 207 shares during the period. Finally, Close Asset Management Ltd bought a new stake in Axcelis Technologies in the 3rd quarter valued at about $27,000. 89.98% of the stock is currently owned by institutional investors and hedge funds.

Axcelis Technologies Trading Down 2.1%

ACLS opened at $161.64 on Wednesday. The company has a debt-to-equity ratio of 0.04, a current ratio of 4.59 and a quick ratio of 2.99. Axcelis Technologies, Inc. has a fifty-two week low of $55.93 and a fifty-two week high of $171.61. The firm has a market capitalization of $4.97 billion, a PE ratio of 50.36, a P/E/G ratio of 13.14 and a beta of 1.93. The company’s 50-day moving average is $110.24 and its 200 day moving average is $94.42.

Axcelis Technologies (NASDAQ:ACLS – Get Free Report) last posted its earnings results on Thursday, May 7th. The semiconductor company reported $0.72 earnings per share for the quarter, topping analysts’ consensus estimates of $0.71 by $0.01. Axcelis Technologies had a net margin of 11.93% and a return on equity of 12.19%. The company had revenue of $198.96 million for the quarter, compared to analyst estimates of $195.03 million. During the same quarter in the prior year, the business posted $0.88 EPS. The firm’s revenue was up 3.3% compared to the same quarter last year. Axcelis Technologies has set its Q2 2026 guidance at 0.900- EPS. As a group, research analysts predict that Axcelis Technologies, Inc. will post 2.86 earnings per share for the current fiscal year.

Insider Transactions at Axcelis Technologies

In related news, CEO Russell Low sold 7,468 shares of the company’s stock in a transaction dated Wednesday, May 6th. The shares were sold at an average price of $156.75, for a total value of $1,170,609.00. Following the sale, the chief executive officer owned 123,570 shares in the company, valued at $19,369,597.50. This represents a 5.70% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Jorge Titinger sold 1,000 shares of the company’s stock in a transaction dated Friday, February 20th. The stock was sold at an average price of $80.00, for a total transaction of $80,000.00. Following the completion of the sale, the director owned 6,477 shares in the company, valued at $518,160. This represents a 13.37% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 10,956 shares of company stock worth $1,540,361 in the last 90 days. 0.49% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

ACLS has been the topic of a number of research reports. Zacks Research raised Axcelis Technologies from a “strong sell” rating to a “hold” rating in a research note on Monday, April 20th. B. Riley Financial upgraded Axcelis Technologies from a “neutral” rating to a “buy” rating and set a $150.00 price objective for the company in a report on Monday, April 20th. Bank of America upped their target price on Axcelis Technologies from $90.00 to $100.00 and gave the stock an “underperform” rating in a research report on Tuesday, January 13th. Finally, Weiss Ratings upgraded Axcelis Technologies from a “hold (c-)” rating to a “hold (c)” rating in a report on Wednesday, April 22nd. Three equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $116.25.

View Our Latest Report on ACLS

Axcelis Technologies Company Profile

(Free Report)

Axcelis Technologies, Inc is a leading developer and manufacturer of ion implantation and cleaning equipment used in the fabrication of semiconductor chips. The company specializes in high-current, medium-current and high-energy ion implantation systems, which are critical for introducing precisely controlled dopants into silicon wafers. Axcelis also offers plasma-based cleaning and dry strip tools that support advanced process nodes in logic, memory and power device manufacturing.

The company’s product portfolio encompasses single-wafer and multi-wafer cluster tools designed to deliver high throughput, accuracy and uniformity for semiconductor process steps.